There are 3397 resources available
Conclusions and perspectives
Presenter: Sanjay Popat
Session: Open questions in immunotherapy for advanced NSCLC: Duration of IO, combinations and rechallenge
Resources:
Webcast
Invited Discussant 377O and 378O
Presenter: Janice Wing-Hang Tsang
Session: Proffered Paper session - Breast cancer, metastatic
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Nicole van Grieken
Session: Upper GI cancers: From bench to bedside
Resources:
Webcast
Invited Discussant 1916MO, 1917MO and 1918MO
Presenter: Kjetil Boye
Session: Mini oral session - Sarcoma
Resources:
Slides
Webcast
2231O - Pan-cancer assessment of the impact of intronic variants on cancer development and progression
Presenter: Anton Safonov
Session: Proffered Paper session 1 - Basic Science and Translational research
Resources:
Abstract
Slides
Webcast
1919MO - Efficacy and safety of botensilimab (BOT) plus balstilimab (BAL) in patients (pts) with refractory metastatic sarcoma
Presenter: Breelyn Wilky
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
Invited Discussant 859MO, 860MO and LBA47
Presenter: Marc Oliva
Session: Mini oral session - Head and neck cancer
Resources:
Slides
Webcast
Invited Discussant 1207O and 2231O
Presenter: Charles Swanton
Session: Proffered Paper session 1 - Basic Science and Translational research
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session - Breast cancer, metastatic
Resources:
Webcast
507MO - REGOMA-OS: A large Italian multicenter, prospective, observational study analyzing regorafenib efficacy and safety in recurrent glioblastoma patients
Presenter: Giuseppe Lombardi
Session: Mini oral session: CNS tumours
Resources:
Abstract
Slides
Webcast